Incannex Healthcare Limited (IXHL) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $-40.77 et chiffre d'affaires de $0.00B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-1.14 vs est $-40.77 (dépassé +97.2%). 2025: réel $-40.80 vs est $-28.80 (manqué -41.7%). Précision des analystes: 0%.
Estimations du BPA — IXHL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.14
vs Est –$40.77
▲ 3,476.4% off
2025
Actual –$40.80
vs Est –$28.80
▼ 29.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Estimations du CA — IXHL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 439.3% off
2025
Actual $0.000B
vs Est $0.000B
▼ 132.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Les autres consultent aussi
